23328-66-7 Usage
Uses
Used in Pharmaceutical Industry:
2,6-DI(OXIRAN-2-YLMETHYL)-1,2,3,5,6,7-HEXAHYDROPYRROLO[3,4-F]ISOINDOLE-1,3,5,7-TETRAONE is used as a potential drug candidate for the development of new medications due to its unique structure and properties.
Used in Organic Synthesis:
2,6-DI(OXIRAN-2-YLMETHYL)-1,2,3,5,6,7-HEXAHYDROPYRROLO[3,4-F]ISOINDOLE-1,3,5,7-TETRAONE is used as a key intermediate in the synthesis of various organic compounds, taking advantage of its reactivity and functional groups.
Used in Materials Science:
2,6-DI(OXIRAN-2-YLMETHYL)-1,2,3,5,6,7-HEXAHYDROPYRROLO[3,4-F]ISOINDOLE-1,3,5,7-TETRAONE is used in the development of advanced materials for various industrial and scientific purposes, leveraging its unique properties and potential for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 23328-66-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,3,2 and 8 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 23328-66:
(7*2)+(6*3)+(5*3)+(4*2)+(3*8)+(2*6)+(1*6)=97
97 % 10 = 7
So 23328-66-7 is a valid CAS Registry Number.
InChI:InChI=1/C16H12N2O6/c19-13-9-1-10-12(16(22)18(14(10)20)4-8-6-24-8)2-11(9)15(21)17(13)3-7-5-23-7/h1-2,7-8H,3-6H2
23328-66-7Relevant academic research and scientific papers
Polymerizable dental composition
-
Paragraph 0122, (2014/08/06)
A dental composition comprising a compound of the following formula (I) wherein A1, A2, A3, A4, and A5 are as defined in claim 1.
POLYMERIZABLE DENTAL COMPOSITION
-
Page/Page column 29-30, (2014/08/07)
A dental composition comprising a compound of the following formula (I) wherein A1, A2, A3, A4, and A5 are as defined in claim 1.
Investigation of the antitumor activity of new epoxide derivatives. II: N-glycidylated oxo-nitrogen heterocyles
Fischer,Moller,Budnowski,et al.
, p. 663 - 668 (2007/10/02)
A number of N-glycidyl compounds derived from oxo-substituted nitrogen heterocycles such as diazines, triazines, diazoles, triazoles as well as condensed ring systems containing these units have been synthesized. All products were tested for their antitumor activity against leukaemia in the mouse. Almost all of the approx. 50 di- and triglycidyl compounds showed activity and 5 of them exhibited an increase of lifespan of 200% and more. The most active compound was 1,2,4-triglycidyl-urazol.